Genomictree Statistics

Total Valuation

Genomictree has a market cap or net worth of KRW 665.42 billion. The enterprise value is 582.59 billion.

Market Cap	665.42B
Enterprise Value	582.59B

Important Dates

The last earnings date was Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Genomictree has 24.02 million shares outstanding. The number of shares has increased by 0.63% in one year.

Current Share Class	24.02M
Shares Outstanding	24.02M
Shares Change (YoY)	+0.63%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	16.02%
Owned by Institutions (%)	0.25%
Float	20.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	177.02
PB Ratio	5.74
P/TBV Ratio	5.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-66.43
EV / Sales	154.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-40.48

Financial Position

The company has a current ratio of 17.19, with a Debt / Equity ratio of 0.02.

Current Ratio	17.19
Quick Ratio	17.01
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-37.76

Financial Efficiency

Return on equity (ROE) is -7.42% and return on invested capital (ROIC) is -6.30%.

Return on Equity (ROE)	-7.42%
Return on Assets (ROA)	-6.04%
Return on Invested Capital (ROIC)	-6.30%
Return on Capital Employed (ROCE)	-10.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	77
Asset Turnover	0.03
Inventory Turnover	8.05

Taxes

In the past 12 months, Genomictree has paid 1.09 million in taxes.

Income Tax	1.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.20% in the last 52 weeks. The beta is 0.16, so Genomictree's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+51.20%
50-Day Moving Average	22,847.40
200-Day Moving Average	17,574.20
Relative Strength Index (RSI)	64.30
Average Volume (20 Days)	189,732

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genomictree had revenue of KRW 3.76 billion and -8.77 billion in losses. Loss per share was -366.23.

Revenue	3.76B
Gross Profit	741.23M
Operating Income	-12.33B
Pretax Income	-8.91B
Net Income	-8.77B
EBITDA	-11.22B
EBIT	-12.33B
Loss Per Share	-366.23

Full Income Statement

Balance Sheet

The company has 85.35 billion in cash and 2.29 billion in debt, giving a net cash position of 83.05 billion or 3,457.37 per share.

Cash & Cash Equivalents	85.35B
Total Debt	2.29B
Net Cash	83.05B
Net Cash Per Share	3,457.37
Equity (Book Value)	115.95B
Book Value Per Share	4,818.74
Working Capital	81.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.68 billion and capital expenditures -2.72 billion, giving a free cash flow of -14.39 billion.

Operating Cash Flow	-11.68B
Capital Expenditures	-2.72B
Free Cash Flow	-14.39B
FCF Per Share	-599.15

Full Cash Flow Statement

Margins

Gross margin is 19.72%, with operating and profit margins of -328.06% and -233.31%.

Gross Margin	19.72%
Operating Margin	-328.06%
Pretax Margin	-236.99%
Profit Margin	-233.31%
EBITDA Margin	-298.51%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genomictree does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.63%
Shareholder Yield	-0.63%
Earnings Yield	-1.32%
FCF Yield	-2.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 14, 2018. It was a forward split with a ratio of 2.

Last Split Date	Sep 14, 2018
Split Type	Forward
Split Ratio	2

Scores

Genomictree has an Altman Z-Score of 35.5 and a Piotroski F-Score of 2.

Altman Z-Score	35.5
Piotroski F-Score	2